A pilot study of brentuximab vedotin combined with AVD chemotherapy and radiotherapy in patients with newly diagnosed early stage, unfavorable risk Hodgkin lymphoma Meeting Abstract
| Authors: | Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L. E.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Constine, L. S.; Dandapani, S.; Drill, E.; Drullinsky, P.; Friedberg, J. W.; Grieve, C.; Hamilton, A.; Hamlin, P. A.; Hoppe, R. T.; Horwitz, S. M.; Matasar, M. J.; McCall, S. J.; Moskowitz, A. J.; Noy, A.; Palomba, M. L.; Schoder, H.; Straus, D. J.; Vemuri, S.; Yang, J. C.; Younes, A.; Zelenetz, A. D.; Yahalom, J.; Moskowitz, C. H. |
| Abstract Title: | A pilot study of brentuximab vedotin combined with AVD chemotherapy and radiotherapy in patients with newly diagnosed early stage, unfavorable risk Hodgkin lymphoma |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000577160406215 |
| DOI: | 10.1182/blood-2019-123150 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2834 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
